JNJ-10280205 and JNJ-10287069: Novel PDE5 inhibitors as clinical candidates for erectile dysfunction.
about
Future prospects in the treatment of erectile dysfunction: focus on avanafil.Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties.Novel phosphodiesterase type 5 modulators: a patent survey (2008 - 2010).In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors.
P2860
JNJ-10280205 and JNJ-10287069: Novel PDE5 inhibitors as clinical candidates for erectile dysfunction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@en
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@nl
type
label
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@en
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@nl
prefLabel
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@en
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@nl
P2093
P2860
P356
P1476
JNJ-10280205 and JNJ-10287069: ...... ates for erectile dysfunction.
@en
P2093
Bhattacharjee S
Haynes-Johnson D
Mathew John T
P2860
P2888
P304
P356
10.1038/SJ.IJIR.3901462
P577
2006-03-09T00:00:00Z